Blockchain Registration Transaction Record

Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO Convention

Tonix Pharmaceuticals to present at 2025 BIO Convention, showcasing TNX-102 SL for fibromyalgia and TNX-4200 antiviral, highlighting innovation in pain and public health solutions.

Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO Convention

The advancements and presentations by Tonix Pharmaceuticals highlight the company's pivotal role in addressing some of the most pressing health challenges today, from fibromyalgia to infectious diseases. Their work not only promises to bring relief to millions suffering from these conditions but also showcases the potential for significant contributions to public health and military readiness. The FDA's Fast Track designation for TNX-102 SL and the DoD's substantial investment in TNX-4200 underscore the importance and potential impact of Tonix's research and development efforts.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x521eb63ebca4668e9f0867a75457f9a4cb17f41d759e739ac20815efad5183b7
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintenvyDjJ0-af4036a3a166ed4ccbde027ca82bdc6e